TPO Ab, RIA CT, 96 tests

The present method is based on a competitive radioimmunoassay (RIA). During the incubation, the monoclonal anti-TPO antibodies in solid phase competes with the sample/calibrator anti-TPO autoantibodies for the specific sites of the 125I labelled TPO (tracer). After aspiration and washing, the radioactivity in the tubes is measured in a gamma counter. The degree of binding will be inversely proportional to the sample anti-TPO autoantibodies concentration. The calibrators of anti-TPO auto-antibodies are calibrated against the TMAb international reference preparation MRC66/387.

Catalog # R-CO-100
Format RIA CT
Label I125
Size 96 tests
Sample Type Serum
Sample Volume 20 µL
Controls 2 levels
Range 40-1000 IU/mL
Sensitivity 7,4 IU/mL
Incubation 1,5h at RT with shaking
Shelf Life (weeks) 9

Due to local registration requirement, this product can not be sold in Canada, United States, Australia – without prior registration.

For Japan and Brazil, specific registration requirements are necessary. For more information, please contact: regulatory.affairs@diasource.be.

Documents - Download
Download "Instructions for Use" R-CO-100.pdf
Download "Material Safety Data Sheet" MSR-CO-100.pdf
Download catalogue "RIA" CATR.pdf
Download RIA Availability Calendar CALRIA21d.pdf
Bridging Science And Diagnostics
Choose my country

DIAsource ImmunoAssays (formerly BioSource), experienced diagnostic manufacturer of RIA-ELISA-LIA immunoassays, validation on automates, large scale production of Antibodies-Point of Care Tests.

Please select your country to see the most accurate content available in your area.